期刊文献+

2型糖尿病合并脂肪肝动物模型制备方法研究 被引量:5

Study on establishment of animal model with diabetes complicated fatty liver induced by streptozocin and nicotinamide
原文传递
导出
摘要 目的探讨建立最佳2型糖尿病合并脂肪肝大鼠模型方案。方法用不同方案给予链脲佐菌素、烟酰胺及高脂饲料干预大鼠8周后,制备脂肪肝动物模型。尾静脉取血,测定空腹血糖(FPG),全自动生化分析仪检测总胆固醇(TC)、三酰甘油(TG)、肝和血清谷丙转氨酶(ALT)、谷草转氨酶(AST);放免法检测空腹胰岛素(FINS),计算肝指数及胰岛素抵抗指数;光镜下观察肝组织改变。结果先注射链脲佐菌素50 mg·kg-1、高脂饲料喂养后,大鼠血糖、血脂、肝功能有显著的变化,组织病理学观察肝细胞出现脂变。结论先注射STZ后高脂饲料喂养可以成功复制糖尿病并脂肪肝动物模型,且符合人类此病的发病特点。 Objective To explore establishment method of ideal rats model with diabetes complicated with fatty liver. Methods SD rats were induced by high -fat, streptozocin and nicoti-namide. The animal model with diabetes complicated fatty liver induced by streptozocin and nieoti- namide was established. Eight weeks later, the serum of total cholesterol ( TC ), triglyceride ( TG), glutamic - pyruvic transaminase ( ALT), glu- tamic oxalacetic transaminase (AST) , fasting glucose (FPG) , fasting in- sulin (FINS) were measured. And the pathological changes of liver tissues were observed. Results There were markedly changes in blood glucose, blood lipid and transaminases and similar histopathology to fatty liver in rats with STZ 50 mg kg-1 and high - fat. Compared with the other groups, this group is more typical and more consistent with diabetes and fatty liver pathologic changes. Conclusion The way of injecting STZ adding high fat - feed can estabilish successfully the animal model of dia- betes with fatty liver. And this model was also in line with human charac- teristics of this desease.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2015年第18期1846-1848,共3页 The Chinese Journal of Clinical Pharmacology
基金 新疆维吾尔自治区高校科研计划基金资助项目(XJEDU2014I020) 国家自然科学基金资助项目(81160546)
关键词 2型糖尿病合并脂肪肝 烟酰胺 链脲佐菌素 动物模型 diabetes complicated fatty liver nicotinamide streptozoto- tin animal model
  • 相关文献

参考文献3

二级参考文献31

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 2葛恒,张俊峰,王彬尧,王长谦.白藜芦醇对PPAR-γ激动作用的研究[J].中国药学杂志,2005,40(12):905-908. 被引量:15
  • 3方朝晖,王佑民,王开成,郭彦,刘玲,胡国平.丹蛭降糖胶囊对胰岛素抵抗大鼠PPAR-γ mRNA表达的影响[J].中国实验方剂学杂志,2006,12(4):36-39. 被引量:25
  • 4Shulman G I.Cellular mechanisms of insulin resistance[J].J Clin Invest,2000,106:171-6.
  • 5Huang T H W,harada M.Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model:role of lowering circulating lipids[J].Br Hournal Pharmacol,2005,145(6):767-74.
  • 6Celik I,Temur A,Isik I.Hepatoprotective role and antioxidant capacity of pomegranate(Punica granatum)flowers infusion against trichloroacetic acid-exposed in rats[J].Food Chem Toxicol,2009,47:145-9.
  • 7Huang T H,Peng G,Kota B P,et al.Anti-diabetic action of Punica granatum flower extract:Activation of PPAR-γ and identification of an active component[J].Toxicol Appl Pharmacol,2005,207(2):160-9.
  • 8Ro tter V,Nagaev I,Smith U.Interleukin-6(IL-6)induces insulin resistance in 3T3-L1 adipocytes and is,like IL-8 and tumor necrosis factor-alpha,overpression in human fat cells from insulin-resistant subjects[J].J Biol Chem,2003,278:45777-84.
  • 9Anandharajan R,Jaiganesh S.In Vitro glucose uptake activity of Aegles marmelos and Syzygium cumini by activation of Glut-4,PI3 kinase and PPARgamma in L6 myotubes[J].Phytomedicine,2006,13(6):434-41.
  • 10Ratziu V,Bellentani S,Cortez-Pinto H,et al.A position statement on NAFLD/NASH based on the EASL 2009 special conference[J].J Hepatol,2010,53(2):372-84.

共引文献10

同被引文献33

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部